Active Biotech has named Tomas Leanderson to become the new president & CEO. Tomas Leanderson has been the CSO for Active Biotech since 1999.
Subscribe to our email newsletter
Previously the company announced that Sven Andreasson has notified the company of his wish to resign from the position as president & CEO.
Sven Andreasson has been the company’s CEO since 1999 and under his leadership Active Biotech is said to have been transformed from a combined vaccine and research company into a company focused on development of novel pharmaceuticals for treatment of cancer and autoimmune diseases.
Sven Andreasson will remain as CEO until September 1, 2008.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.